Valtruis invests in, builds, and partners with early-stage to growth-stage companies that challenge the healthcare industry's status quo and accelerate the adoption of value-based care.
About Valtruis
Valtruis is a US-based healthcare-focused investment platform at valtruis.com with active LinkedIn and Crunchbase presence, positioned around value-based care transformation and partnerships with provider and payer organizations. While the input record does not specify stages or check sizes, Valtruis is publicly understood as a growth-stage capital partner that backs operating companies driving the shift from fee-for-service to value-based payment models, often through joint ventures, scale-up capital, and operational partnership rather than pure passive equity. For healthcare AI founders, Valtruis is a relevant target if you are building infrastructure, analytics, or care-delivery software directly enabling value-based contracts, ACO performance, risk adjustment accuracy, or population health management, and you have meaningful revenue and clinical traction. Early-stage software companies without payer or provider commercial validation are not the right fit; this is later-stage capital with a strategic depth that requires founders to come ready for a serious diligence cycle. Likely check sizes for a platform of this profile span USD 10M to USD 50M, with capacity for control-style investments and structured transactions. Best entry path is a banker-led process or a warm introduction through a US value-based care ecosystem connector, particularly partners at major ACOs, MA plans, or specialty risk-bearing providers. The first meeting should center on payer contracts, MLR impact, attribution methodology, and demonstrated cost-of-care reductions, not product features. Founders without value-based care fluency will struggle here.
Founder reviews
Healthcare AI tools backed by Valtruis
Tools made by companies in Valtruis's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Valtruis's portfolio not currently in our directory.
- Autonomize AI · 2025
- Arbiter
- Arbital Health · 2025
- Sevaro · 2025
- Nadia Care · 2026
- Wayspring · 2024
- InStride Health · 2022
- Wellvana · 2023
- TailorCare · 2023
- HarmonyCares · 2024
- InterWell Health
Team
Pitch / review this investor
Have you raised from Valtruis? Founders only — share your honest experience (anonymous OK, moderated before publishing).

